129 - Improved metabolic syndrome-related right and left ventricular dysfunction by the dual ETA-ETB receptor antagonist macitentan

Autor: Lachaux, M., Harouki, N., Peschanski, N., Nicol, L., Dumesnil, A., Henry, J.P., Renet, S., Jouet, I., Iglarz, M., Richard, V., Mulder, P.
Zdroj: In Archives of Cardiovascular Diseases Supplements April 2017 9(2):205-206
Databáze: ScienceDirect